Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2000-02-14
2004-07-06
Canella, Karen A. (Department: 1642)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252300, C435S320100, C435S325000, C536S023100, C536S023500, C536S024500
Reexamination Certificate
active
06759212
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a gene encoding a novel cell cycle control protein AIM-1 (aurora and IPL-1 like midbody-associated protein kinase), recombinant vectors containing said gene, cells transformed with said vectors, processes for producing AIM-1 using said gene and recombinant AIM-1 proteins obtained by said processes. The present invention also relates to oligonucleotide or peptide nucleic acids capable of specifically hybridizing to a nucleotide sequence encoding AIM-1 protein, antibodies recognizing AIM-1, therapeutic agents for diseases associated with abnormal cell growth comprising an inhibitor against AIM-1 protein, and screening methods for materials having serine-threonine inhibitory activity using AIM-1 gene or AIM-1 protein.
PRIOR ART
Mitosis is a fundamental mode of nuclear division of eukaryotic cells and a highly coordinated process by which eukaryotic cells assure the fidelity of chromosome segregation. The number of chromosomes is often a multiple of the basic number unique to the species, but errors during mitosis result in an individual having one to several chromosomes added to or deleted from the multiple (aneuploid), which may cause cell death or oncogenesis.
Aurora (Glover et al., Cell 81:95-105, 1995) in Drosophia (Drosophia melanogaster) and its most closely related IPL-1 (Francisco et al., Mol. Cell. Biol. 14:4731-40, 1994) in budding yeast (Saccharomyces cerevisiae) are molecules participating in M phase of mitosis and are thought to be required for high-fidelity chromosome segregation.
However, no molecules corresponding to aurora or IPL-1 have been so far reported in mammals. If a gene encoding a molecule controlling the cell cycle in mammals were available and its functions explained, it would be very interesting for pharmaceutical applications such as anticancer agents.
An object of the present invention is to search for a molecule controlling the cell cycle in mammals to determine the nucleotide sequence of a gene encoding the same, produce such a molecule by gene recombinant techniques using a recombinant vector containing said sequence, and show a potential for development of novel medicaments by constructing a screening system or the like using the same.
SUMMARY OF THE INVENTION
The inventors succeeded in isolating a gene encoding a novel cell cycle control protein kinase AIM-1 (aurora and IPL-1 like midbody-associated protein kinase) by screening a cDNA library of rats using a conserved sequence in serine-threonine kinase domain (FEBS LETT. 320:246-250, 1993) as a probe, and in explaining its functions.
Accordingly, the present invention provides a DNA containing a nucleotide sequence encoding the amino acid sequence shown as SEQ ID NO: 2 in Sequence Listing, or a nucleotide sequence encoding a protein having the amino acid sequence shown as SEQ ID NO: 2 in Sequence Listing with partial substitution, deletion or addition and having cell cycle control activity, or a nucleotide sequence hybridizing to them.
The present invention also provides a recombinant vector containing a gene encoding AIM-1 protein.
The present invention also provides a prokaryotic or eukaryotic host cell transformed with a recombinant vector containing a gene encoding AIM-1 protein.
The present invention also provides a process for producing AIM-1 protein, comprising culturing a cell transformed with a recombinant vector containing a gene encoding AIM-1 protein, and isolating and purifying the target protein produced.
The present invention also provides a recombinant AIM-1 protein produced by said process.
The present invention also provides an oligonucleotide or peptide nucleic acid capable of specifically hybridizing to a gene encoding AIM-1 protein.
The present invention also provides an antibody recognizing a peptide having at least five continuous amino acids in the amino acid sequence shown as SEQ ID NO: 2 in Sequence Listing.
The present invention also provides a therapeutic agent for diseases associated with abnormal cell growth comprising an inhibitor against AIM-1 protein.
The present invention also provides a screening method for materials having serine-threonine inhibitory activity using AIM-1 gene or AIM-1 protein.
We also tested how AIM-1 is expressed during each stage of cell division and examined the role of AIM-1 in the cell cycle.
REFERENCES:
patent: 5962312 (1999-10-01), Plowman et al.
patent: 97/22702 (1997-06-01), None
Varmus, H., “Historical Review of Oncogenesis” in Oncogenes and the Molecular Origins of Cancer, 1989, p. 36.*
Hagemeijer, A, “Cytogenetics and Oncogenes”, Leukemia, 1992, vol. 6, Suppl. 4, pp. 16-18.*
Alberts et al, The Molecular Biology of the Cell (textbook), 2nd ed., 1989, p. 1203.*
Sheeny et al, Cancer Research, 1974, vol. 34, pp. 991-996.*
Demidova et al, “A comparative study of primary human cell cultures of diffuse goiter and cancer or the thyroid gland”, Voprosy Onkologii, 1975, vol. 21, pp. 833-88, (Abstract only).*
Takeichi et al, “Studies on tumors produced by cells transformed with herpes simplex virus type-2”, Gann, 1977, vol. 68, pp. 653-661, (abstract only).*
Burgess et al, “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding Growth Factor-1”, Journal of Cell biology, 1990, vol. 111, pp. 2129-2138.*
Lazar et al, “Transforming growth factor-alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities”, Molecular and Cellular biology, 1988, vol. 8, pp. 1247-1252.*
Branch, A., “A hitchhiker's guide to antisense and nonantisense biochemical pathways”, Hepatology, 1996, vol. 24, pp. 1517-1529.*
Broaddus et al, “Strategies for the design and delivery of antisense oligonucleotides in central nervous system”, Methods in Enzymology, vol. 314, pp. 121-135.*
M. Shindo et al., “cDNA Cloning, Expression, Subcellular Localization, and Chromosomal Assignment of Mammalian Aurora Homologues, Aurora-Related Kinase (ARK) 1 and 2”, Biochemical and Biophysical Research Communications, 1998 by Academic Press, vol. 244, (285-292).
Y. Terada et al., “AIM-1: A mammalian midbody-associated protein required for cytokinesis” EMBO Journal, Oxford University Press, 1998 vol. 17, (667-676).
Kuniya Abe, “Rapid isolatio of desired sequences from lone linker PCR amplified cDNA mixtures: Application to identification and recovery of expressed sequences in cloned genomic DNA.”, Mammalian Genome vol. 2, pp. 252-259, 1992.
Fioina J. Clay et al., “Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila.”, Proceedings of the National Academy of Science, vol. 90, pp. 4882-4886, 1993.
Brian Fenton et al., “A conserved mitotic kinase active at late anaphase-telophase in syncytial Drosophila embryos.”, Nature, vol. 363, pp. 637-640, 1993.
Leigh Francisco et al., “Type 1 Protein Phosphatase Acts in Opposition to IpI1 Protein Kinase in Regulating Yeast Chromosome Segregation.”, Molecular and Cellular Biology, pp. 4731-4740, 1994.
Hironori Funabiki et al., “Cut2 proteolysis required for sister-chromatid separation in fission yeast.”, Nature, vol. 381, pp. 438-441, 1996.
Michael Glotzer et al., “Cyclin is degraded by the ubiquitin pathway.”, Nature, vol. 349, pp. 132-138, 1991.
David M. Glover et al., “Mutations in aurora Prevent Centrosome Separation Leading to the Formation of Monopolar Spindles.”, Cell, vol. 81, pp. 95-105, 1995.
Lawrence S. B. Goldstein, “The kinesin superfamily: tails of functional redundancy.”, Trends in Cell biology, vol. 1, pp. 93-99, 1991.
Roy M. Golsteyn et al., “Cell Cycle Regulation of the Activity and Subcellular Localization of PLK1, a Human Protein Kinase Implicated in Mitotic Spindle Function.”, The Journal of Cell Biology, vol. 129, No. 6, pp. 1617-1628, 1995.
Manfred Gossen et al., “Tight control of gene expression in mammalian cells by tetracycline responsive promoters.”, Proceedings of the National Academy of Science, vo. 89, pp. 5547-5551, 1992.
Steven K. Hanks et al., “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains.”,
Tatsuka Masaaki
Terada Yasuhiko
Canella Karen A.
Chugai Seiyaku Kabushiki Kaisha
Foley & Lardner
LandOfFree
Cell cycle-regulating proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell cycle-regulating proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell cycle-regulating proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3204010